Remogliflozin (Remo), an inhibitor of the sodiumglucose cotransporter 2 (SGLT2) protein, is one of the most recently developed antidiabetic drugs for treating type 2 diabetes mellitus (T2DM)
It is a long-acting amylin analog, a completely different mechanism from the GLP-1 receptor agonists that dominate the conversation right now
Biomedicines 11:43 Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S (2012) Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b: H4-ST131 Escherichia coli strain producing CTX-M-15
The impact of propofol is not clear, and theophyllline concentrations were not measured to confirm adequate concentrations
Reference: (1) Jean-Louis Guant, Rosa-Maria Guant-Rodriguez, and David H Alpers (2022) Vitamin B12 absorption and malabsorption Vitamins and Hormones, 2022, Volume 119, Pages 241-274